- Home
- ACR vs KRRO Comparison
ACR vs KRRO Comparison
Compare ACR & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- KRRO
- Stock Information
- Founded
- ACR 2005
- KRRO 2014
- Country
- ACR United States
- KRRO United States
- Employees
- ACR N/A
- KRRO N/A
- Industry
- ACR Real Estate Investment Trusts
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- ACR Real Estate
- KRRO Health Care
- Exchange
- ACR Nasdaq
- KRRO Nasdaq
- Market Cap
- ACR 139.0M
- KRRO 147.4M
- IPO Year
- ACR N/A
- KRRO 2019
- Fundamental
- Price
- ACR $21.04
- KRRO $20.04
- Analyst Decision
- ACR Buy
- KRRO Strong Buy
- Analyst Count
- ACR 2
- KRRO 7
- Target Price
- ACR $17.50
- KRRO $96.71
- AVG Volume (30 Days)
- ACR 23.0K
- KRRO 128.5K
- Earning Date
- ACR 07-30-2025
- KRRO 08-12-2025
- Dividend Yield
- ACR N/A
- KRRO N/A
- EPS Growth
- ACR N/A
- KRRO N/A
- EPS
- ACR 0.04
- KRRO N/A
- Revenue
- ACR $86,599,000.00
- KRRO $6,281,000.00
- Revenue This Year
- ACR $3.57
- KRRO $65.08
- Revenue Next Year
- ACR N/A
- KRRO N/A
- P/E Ratio
- ACR $507.61
- KRRO N/A
- Revenue Growth
- ACR 12.74
- KRRO N/A
- 52 Week Low
- ACR $14.87
- KRRO $10.29
- 52 Week High
- ACR $23.81
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- ACR 78.09
- KRRO 64.81
- Support Level
- ACR $18.67
- KRRO $18.52
- Resistance Level
- ACR $20.58
- KRRO $21.08
- Average True Range (ATR)
- ACR 0.42
- KRRO 1.67
- MACD
- ACR 0.07
- KRRO 0.29
- Stochastic Oscillator
- ACR 94.22
- KRRO 78.80
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.